…
Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Advantis Corp (OTC: ADVT) is an OTC-listed company for which public disclosures and verifiable operational details are limited, making its core business activities and financial profile unclear. Potential long-term growth drivers are therefore uncertain, though investors may find exposure to an underfollowed microcap attractive if the company clarifies strategy, secures financing, or demonstrates operational progress.
Primary investment risks include very low liquidity, limited analyst and regulatory scrutiny, heightened volatility and potential for significant dilution or difficulty accessing reliable financial information common to OTC microcap issuers.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | - | - | - | - | -0.02M |
| Net income | - | - | - | - | -0.02M |
| Gross profit | - | - | - | - | 0.76M |
| Ebitda | - | - | - | - | -0.02M |
| Depreciation and amortization | 0.23M | 0.24M | 0.21M | 0.17M | - |
| Operating income | - | - | - | - | -0.02M |
| Other operating expenses | - | - | - | - | 0.85M |
| Interest expense | - | - | - | - | 0.00M |
| Total revenue | - | - | - | - | 0.83M |
| Total operating expenses | - | - | - | - | 0.79M |
| Cost of revenue | - | - | - | - | 0.06M |
| Total other income expense net | - | - | - | - | -0.00M |
| Breakdown | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Total assets | 0.54M | 0.27M | 0.05M | 0.01M | 0.00M |
| Other current assets | 0.22M | 0.10M | 0.00M | - | - |
| Total liab | 1.84M | 1.52M | 1.34M | 1.29M | 1.39M |
| Total stockholder equity | -1.30M | -1.26M | -1.29M | -1.28M | -1.39M |
| Other current liab | 1.12M | - | - | - | - |
| Common stock | 0.10M | 0.10M | 0.08M | 0.07M | 0.07M |
| Retained earnings | -1.65M | -1.65M | -1.53M | -1.43M | -1.53M |
| Cash | 0.30M | 0.14M | 0.01M | 0.01M | 0.00M |
| Total current liabilities | 1.12M | 0.80M | 0.48M | 0.43M | 1.39M |
| Net debt | 0.42M | - | - | - | - |
| Short term debt | - | 0.36M | 0.25M | 0.36M | 0.16M |
| Short long term debt | - | 0.36M | 0.25M | 0.36M | 0.16M |
| Short long term debt total | 0.72M | - | - | - | - |
| Other stockholder equity | 0.25M | - | - | - | - |
| Total current assets | 0.54M | 0.27M | 0.05M | 0.01M | 0.00M |
| Net tangible assets | - | -1.26M | -1.29M | -1.28M | -1.39M |
| Net receivables | 0.03M | 0.02M | 0.03M | - | - |
| Long term debt | - | 0.72M | 0.85M | 0.85M | - |
| Inventory | - | 0.01M | 0.01M | - | - |
| Accounts payable | 0.00M | 0.44M | 0.23M | 0.07M | 1.23M |
| Accumulated other comprehensive income | -0.00M | - | - | - | - |
| Breakdown | 2019-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2019-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Change to liabilities | - | 0.19M | 0.07M | -0.98M | 0.06M |
| Total cashflows from investing activities | - | -0.10M | -0.10M | -0.10M | - |
| Net borrowings | - | - | -0.02M | 0.88M | 0.88M |
| Total cash from financing activities | - | 0.03M | 0.08M | 0.88M | 0.02M |
| Change to operating activities | - | 0.02M | -0.04M | -0.04M | -0.04M |
| Net income | - | -0.11M | -0.11M | 0.11M | -0.08M |
| Change in cash | - | 0.13M | 0.00M | 0.01M | 0.00M |
| Begin period cash flow | 0.30M | - | - | - | - |
| End period cash flow | 0.30M | - | - | - | - |
| Total cash from operating activities | - | 0.09M | -0.08M | -0.87M | -0.02M |
| Sale purchase of stock | - | 0.13M | 0.10M | 0.10M | 0.02M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MKKGY Merck KGaA ADR |
-0.74 2.19% |
33.06 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
170.05 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.34 1.66% |
21.18 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
41.72 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.
1048 Irvine Avenue, Newport Beach, CA, United States, 92660
949-354-3585
5
| Name | Title | Year Born |
|---|---|---|
| Mr. Darren Cherry | Chief Exec. Officer | NA |
| Mr. Geoffrey Broderick | Corp. Counsel | NA |
| Mr. Chris Thue | Chief Compliance Officer of Operations | NA |
| Mr. Darren Cherry | Chief Executive Officer | NA |
| Mr. Geoffrey Broderick | Corporate Counsel | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.